Profusa (PFSA) Cash from Investing Activities (2022 - 2026)

Profusa's (PFSA) quarterly Cash from Investing Activities came in at $1.1 million in Q1 2026, down 82.36% year-on-year from $6.5 million in Q1 2025, and up 213.59% quarter-over-quarter from -$1.0 million in Q4 2025.

Profusa (PFSA) Cash from Investing Activities (2022 - 2026) Analysis & Trends

Profusa's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at $1.1 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 82.36% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was -$7.4 million, a 206.55% decrease from a year earlier, with the FY2025 full-year figure at -$2.0 million, down 167.66% from the prior year.
  • Cash from Investing Activities rose to $1.1 million in Q1 2026 per PFSA's latest filing, from -$1.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $185.7 million in Q1 2023 and bottomed at -$7.5 million in Q3 2025.
  • The 5-year median for Cash from Investing Activities is $32631.5 (2024), against an average of $13.4 million.
  • Across the five-year window, Cash from Investing Activities plunged 206421.62% in 2023 and surged 699.29% in 2024, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$37.0 in 2022, then plunged by 206421.62% to -$76413.0 in 2023, then jumped by 699.29% to $457936.0 in 2024, then sank by 320.12% to -$1.0 million in 2025, then soared by 213.59% to $1.1 million in 2026.
  • Per Business Quant, the three latest PFSA Cash from Investing Activities figures stand at $1.1 million (Q1 2026), -$1.0 million (Q4 2025), and -$7.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 181.51 Bn 174.22 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.20 Bn 125.32 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.69 Bn 98.47 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 68.05 Bn 66.59 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 47.52 Bn 43.85 Bn 1.29 Bn -92.80 Mn
6 GE HealthCare Technologies 28.46 Bn 26.17 Bn 1.98 Bn -2.50 Bn
7 Dexcom 28.25 Bn 27.13 Bn 750.30 Mn -298.50 Mn
8 Smith & Nephew 26.73 Bn 26.15 Bn - -
9 Koninklijke Philips 25.31 Bn 22.19 Bn 2.07 Bn -475.32 Mn
10 Profusa 84,405.00 -290,595.00 - 1.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.15 Mn
Mar 31, 2026 1.15 Mn
Dec 31, 2025 -1.01 Mn
Dec 31, 2025 -1.01 Mn
Sep 30, 2025 -7.49 Mn
Sep 30, 2025 -7.49 Mn
Jun 30, 2025 -1.00
Jun 30, 2025 -1.00
Mar 31, 2025 6.49 Mn
Mar 31, 2025 6.49 Mn
Dec 31, 2024 457,936.00
Dec 31, 2024 457,936.00
Sep 30, 2024 -112,115.00
Sep 30, 2024 -112,115.00
Jun 30, 2024 65,264.00
Jun 30, 2024 65,264.00
Mar 31, 2024 2.56 Mn
Mar 31, 2024 2.56 Mn
Dec 31, 2023 -76,413.00
Dec 31, 2023 -76,413.00